Fungal lung disease
Open Access
- 3 October 2024
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (5) , 2400803
Abstract
Fungal lung disease encompasses a wide spectrum of organisms and associated clinical conditions, presenting a significant global health challenge. The type and severity of disease are determined by underlying host immunity and infecting fungal strain. The most common group of diseases are associated with the filamentous fungusAspergillusspecies and include allergic bronchopulmonary aspergillosis, sensitisation, aspergilloma and chronic and invasive pulmonary aspergillosis. Fungal lung disease remains epidemiologically heterogenous and is influenced by geography, environment and host comorbidities. Diagnostic modalities continue to evolve and now include novel molecular assays and biomarkers; however, persisting challenges include achieving rapid and accurate diagnosis, particularly in resource-limited settings, and in differentiating fungal infection from other pulmonary conditions. Treatment strategies for fungal lung diseases rely mainly on antifungal agents but the emergence of drug-resistant strains poses a substantial global threat and adds complexity to existing therapeutic challenges. Emerging antifungal agents and increasing insight into the lung mycobiome may offer fresh and personalised approaches to diagnosis and treatment. Innovative methodologies are required to mitigate drug resistance and the adverse effects of treatment. This state-of-the-art review describes the current landscape of fungal lung disease, highlighting key clinical insights, current challenges and emerging approaches for its diagnosis and treatment.Keywords
Funding Information
- Ministry of Education - Singapore (AcRF Tier 1 Grant (RT1/22))
- National Medical Research Council (MOH-000710, MOH-000955, MOH-001275-00, MOH-001356)
This publication has 283 references indexed in Scilit:
- A Randomized Trial of Itraconazole in Allergic Bronchopulmonary AspergillosisNew England Journal of Medicine, 2000
- Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patientsThe Annals of Thoracic Surgery, 1999
- Imaging Features of Pneumocystis carinii PneumoniaCritical Reviews in Computed Tomography, 1999
- Laboratory diagnosis of Pneumocystis carinii infections by PCR directed to genes encoding for mitochondrial 5S and 28S ribosomal RNADiagnostic Microbiology and Infectious Disease, 1999
- Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome.1998
- Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and OutcomeClinical Infectious Diseases, 1995
- Lung cavitation associated with Pneumocystis carinii infection in the acquired immunodeficiency syndrome: a report of six cases and review of the literatureEuropean Respiratory Journal, 1994
- Exposure to an Aeroallergen as a Possible Precipitating Factor in Respiratory Arrest in Young Patients with AsthmaNew England Journal of Medicine, 1991
- Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDSAmerican Review of Respiratory Disease, 1989
- ASPERGILLOSIS AND ATOPY IN CYSTIC-FIBROSIS1979